Summit Global Investments - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 64 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2021. The put-call ratio across all filers is 1.19 and the average weighting 1.5%.

Quarter-by-quarter ownership
Summit Global Investments ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q2 2021$208,00048,5000.01%
Other shareholders

There were no reported owners of LA JOLLA PHARMACEUTICAL CO in Q2 2021.

NameSharesValueWeighting ↓
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders